February 2023

Therapeutic Antibody Discovery: From Target to Candidate

2024-12-03T13:57:42-05:00February 24th, 2023|Articles|

Written by: Genya Gorshtein, MSc Published: February 17, 2023 Contents The Drug Development Pathway Target Discovery and Validation Antibody Discovery Characterization and Lead Selection Engineering and Optimization Candidate Selection Therapeutic Antibody Discovery with Rapid Novor The Drug Development Pathway The four phases in the drug [...]

Read More
 0

September 2022

Antibody-Drug Conjugates as Anti-Cancer Therapeutics

2024-01-22T13:13:13-05:00September 19th, 2022|Articles|

Written by: Genya Gorshtein, MSc Published: September 14, 2022 Contents Introduction ADCs as Novel Anti-Cancer Chemotherapeutics Key Components of ADCs Future Generation of ADCs De Novo Protein Sequencing Applications in ADC Development Introduction An antibody-drug conjugate (ADC) is a monoclonal antibody (mAb) with a covalently attached [...]

Read More
 0
Services
Science
About
Other programs

Locations

Unit 450, 137 Glasgow St.,
Kitchener, Ontario, Canada N2G 4X8

Johan Enschedeweg 13,
Uithoorn, 1422 DR, The Netherlands

135 Beaver Street, Suite 204.
Waltham, MA 02452. USA

11421 West Bernardo Court
San Diego, CA 92127

 

© 2024 Rapid Novor, Inc. Unit 450, 137 Glasgow St., Kitchener, Ontario, Canada, N2G 4X8 | Antibody & Protein Sequencing, Discovery & Characterization Company | All Rights Reserved | Privacy Policy | Accessibility Notice | Terms of Service

Services
Applications
Science
About

© 2024 Rapid Novor, Inc. Unit 450, 137 Glasgow St., Kitchener, Ontario, Canada, N2G 4X8 | All Rights Reserved | Privacy Policy | Accessibility Notice | Terms of Service

© 2024 Rapid Novor, Inc. Unit 450, 137 Glasgow St., Kitchener, Ontario, Canada, N2G 4X8 | All Rights Reserved | Privacy Policy | Accessibility Notice | Terms of Service